Kucuk, T., Kozinoglu, H. and Kaba, A. (2008) Growth Hormone Co-Treatment within a GnRH Agonist Long Protocol in Patients with Poor Ovarian Response: A Prospective, Randomized, Clinical Trial. Journal of Assisted Reproduction and Genetics, 25, 123-127.
https://doi.org/10.1007/s10815-008-9212-7

has been cited by the following article:

• TITLE: GnRH Antagonist Protocol: Is It Effective for Expected Poor Ovarian Responders with Tubal Factor Undergoing IVF?

  AUTHORS: Weijie Xing, Haiyan Lin, Qingxue Zhang

  KEYWORDS: Poor Ovarian Responders, GnRH Antagonist Protocol, GnRH Agonist Protocol

  JOURNAL NAME: Advances in Reproductive Sciences, Vol.5 No.4, October 24, 2017

  ABSTRACT: Background: This study aimed to determine if the gonadotropin releasing hormone (GnRH) antagonist protocol is optimal for expected poor ovarian responders with tubal factor undergoing in vitro fertilization-embryo transfer (IVF-ET). Methods: A total of 341 IVF-ET cycles were retrospectively identified. The following inclusion criteria were applied: age ≥ 40 years and patients with tubal factors. The cycles were divided into two groups: a GnRH antagonist group (157 cycles) and a GnRH agonist group (184 cycles). Results: The duration of stimulation and the total doses of gonadotropin in the GnRH agonist group were significantly more than those in the GnRH antagonist group (P